Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
基本信息
- 批准号:8939810
- 负责人:
- 金额:$ 32.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:13q12-1313q1413q14.314qAmericanBRCA2 geneBiologicalBiological ProcessCXCL12 geneCadherinsCancer Cell GrowthCancer EtiologyCathepsinsCell AdhesionCell ProliferationCell surfaceCellsCessation of lifeChromosomesColon CarcinomaColonic NeoplasmsDiagnosisDiagnosticEctopic ExpressionEvaluationExonsFamilyFamily memberGene ExpressionGene Expression ProfileGene ProteinsGene TargetingGenesGeneticGlycoproteinsGoalsHumanHuman GenomeIn VitroInflammationKnockout MiceLectinLoss of HeterozygosityMalignant neoplasm of prostateMessenger RNAMetastatic Neoplasm to the BoneMolecularMusNatural ImmunityNeoplasm MetastasisPlayProstateProstate AdenocarcinomaProstatic Intraepithelial NeoplasiasProstatic NeoplasmsRB1 geneReportingRetinoblastomaRoleSamplingSeminal fluidSerumSignaling Pathway GeneSolid NeoplasmSonic hedgehog proteinStem cellsStomach NeoplasmsSusceptibility GeneTissuesTumor Suppressor GenesTumor Suppressor Proteinsage relatedcancer typecell growthepithelial to mesenchymal transitionforkhead proteingene functionhuman GW112 proteinimprovedin vivomalignant breast neoplasmmalignant stomach neoplasmmenmouse modelnovel markerolfactomedinoutcome forecastprognosticprostate cancer cellsmoothened signaling pathwaystemtherapeutic targettumor progression
项目摘要
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein. OLFM4 is normally expressed in a limited number of tissues, including the prostate, but its biological functions in prostate are largely unknown. Loss of olfactomedin 4 (OLFM4) gene expression is associated with high grade of human prostate cancer. Genetics studies have found that deletions within the olfactomedin 4 (OLFM4) gene occur in approximately 25% of human prostate-cancer samples. To explore cellular and molecular mechanisms underlying OLFM4 functions, we investigated Olfm4-knockout mouse model and human prostate cancer cells that lack OLFM4 expression. Phenotypically studies of prostate from Olfm4-knockout mice found that sporadically developed prostatic intraepithelial neoplasia and prostatic adenocarcinoma in an age-dependent manner. The gene-expression signature of prostate tissues from Olfm4-knockout mice at 3 month-old and 15 month-old revealed significant changes for genes associated with prostate neoplastic progression. Sonic hedgehog-signaling pathway and target genes were significantly up-regulated in prostate from Olfm4-knockout mice. Importantly, we found Olfactomedin 4 inhibits prostate stem/progenitor cell growth and epithelial-to-mesenchymal transition (EMT) through down-regulated the hedgehog-signaling pathway genes and target genes activities. Moreover, we demonstrated that OLFM4 inhibited the hedgehog-signaling pathway via direct interaction with sonic hedgehog protein. These findings suggest that OLFM4 plays a critical role in prostate neoplastic progression and that OLFM4 protein has potential as a new marker for improving diagnostic/prognostic accuracy and likely targets for therapeutic approaches to prostate cancer.
人嗅觉调节蛋白4基因(OLFM 4)编码一种嗅觉调节蛋白相关糖蛋白。OLFM 4通常在包括前列腺在内的有限数量的组织中表达,但其在前列腺中的生物学功能在很大程度上是未知的。嗅觉调节蛋白4(OLFM 4)基因表达的缺失与高级别的人前列腺癌相关。遗传学研究发现,在大约25%的人类前列腺癌样本中发生了嗅觉调节蛋白4(OLFM 4)基因的缺失。为了探索OLFM 4功能的细胞和分子机制,我们研究了OLFM 4敲除小鼠模型和缺乏OLFM 4表达的人前列腺癌细胞。对Olfm 4基因敲除小鼠前列腺的表型研究发现,以年龄依赖性方式零星发生前列腺上皮内瘤变和前列腺腺癌。来自3个月大和15个月大的Olfm 4敲除小鼠的前列腺组织的基因表达特征揭示了与前列腺肿瘤进展相关的基因的显著变化。Olfm 4基因敲除小鼠前列腺中的Sonic hedgehog信号通路和靶基因表达显著上调。重要的是,我们发现Olfactomedin 4通过下调hedgehog信号通路基因和靶基因活性来抑制前列腺干/祖细胞生长和上皮-间质转化(EMT)。此外,我们证明了OLFM 4通过与音刺猬蛋白直接相互作用来抑制刺猬信号通路。这些发现表明,OLFM 4在前列腺肿瘤进展中起着关键作用,OLFM 4蛋白有潜力作为一种新的标志物,用于提高诊断/预后的准确性和可能的目标,前列腺癌的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRIFFIN RODGERS其他文献
GRIFFIN RODGERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRIFFIN RODGERS', 18)}}的其他基金
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
- 批准号:
8557968 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
- 批准号:
8557970 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
8939812 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
胶质细胞成熟因子-γ负调节巨噬细胞中的 TLR4 信号传导
- 批准号:
8149534 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
- 批准号:
8149535 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
9157363 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
- 批准号:
8344821 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
- 批准号:
8557967 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
9357228 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
Olfactomedin 4 is a key regulator of human neutrophil function
Olfactomedin 4 是人类中性粒细胞功能的关键调节剂
- 批准号:
10012677 - 财政年份:
- 资助金额:
$ 32.92万 - 项目类别:
相似国自然基金
CTCF通过介导染色体13q14 基因组区异常构象促进视网膜母细胞瘤发生的机制研究
- 批准号:81802739
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
13q14染色体缺失通过下调miRNA表达参与多发性骨髓瘤血管新生
- 批准号:30700331
- 批准年份:2007
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
相似海外基金
RNASEH2B loss to predict response to PARP inhibitor in prostate cancer
RNASEH2B 缺失可预测前列腺癌对 PARP 抑制剂的反应
- 批准号:
10403681 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
RNASEH2B loss to predict response to PARP inhibitor in prostate cancer
RNASEH2B 缺失可预测前列腺癌对 PARP 抑制剂的反应
- 批准号:
10199307 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
10250318 - 财政年份:2015
- 资助金额:
$ 32.92万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9321279 - 财政年份:2015
- 资助金额:
$ 32.92万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9763332 - 财政年份:2015
- 资助金额:
$ 32.92万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9143733 - 财政年份:2015
- 资助金额:
$ 32.92万 - 项目类别:
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
多发性骨髓瘤发病机制中 T(4;14) 易位的分子靶点
- 批准号:
9187811 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:
The Role of THSD1 in Endothelial Cell Adhesion and Survival
THSD1 在内皮细胞粘附和存活中的作用
- 批准号:
8824389 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
多发性骨髓瘤发病机制中 T(4;14) 易位的分子靶点
- 批准号:
8997472 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:














{{item.name}}会员




